Filtros : "Dissolution Technologies" Limpar

Filtros



Refine with date range


  • Source: Dissolution Technologies. Unidade: FCF

    Subjects: CÁLCIO, OSTEOPOROSE, SUPLEMENTOS DIETÉTICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Rosana Pereira da et al. Dissolution profile of calcium supplements in Brazil: a critical analysis and formulation proposal. Dissolution Technologies, v. 30, n. 3, p. 154-161, 2023Tradução . . Disponível em: https://doi.org/10.14227/DT300323P154. Acesso em: 02 maio 2024.
    • APA

      Silva, R. P. da, Issa, M. G., Bezzon, V. D. N., Rodrigues, A. G., & Ferraz, H. G. (2023). Dissolution profile of calcium supplements in Brazil: a critical analysis and formulation proposal. Dissolution Technologies, 30( 3), 154-161. doi:10.14227/DT300323P154
    • NLM

      Silva RP da, Issa MG, Bezzon VDN, Rodrigues AG, Ferraz HG. Dissolution profile of calcium supplements in Brazil: a critical analysis and formulation proposal [Internet]. Dissolution Technologies. 2023 ; 30( 3): 154-161.[citado 2024 maio 02 ] Available from: https://doi.org/10.14227/DT300323P154
    • Vancouver

      Silva RP da, Issa MG, Bezzon VDN, Rodrigues AG, Ferraz HG. Dissolution profile of calcium supplements in Brazil: a critical analysis and formulation proposal [Internet]. Dissolution Technologies. 2023 ; 30( 3): 154-161.[citado 2024 maio 02 ] Available from: https://doi.org/10.14227/DT300323P154
  • Source: Dissolution Technologies. Unidade: FCF

    Subjects: TRATO GASTROINTESTINAL, FARMACOCINÉTICA, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Daniela Amaral et al. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, v. 29, n. 2, p. 62-75, 2022Tradução . . Disponível em: https://doi.org/10.14227/DT290222P62. Acesso em: 02 maio 2024.
    • APA

      Silva, D. A., Davies, N. M., Bou-Chacra, N. A., Ferraz, H. G., & Löbenberg, R. (2022). Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, 29( 2), 62-75. doi:10.14227/DT290222P62
    • NLM

      Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 maio 02 ] Available from: https://doi.org/10.14227/DT290222P62
    • Vancouver

      Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 maio 02 ] Available from: https://doi.org/10.14227/DT290222P62
  • Source: Dissolution Technologies. Unidade: FCF

    Subjects: FARMACOCINÉTICA, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Daniela Amaral et al. The Significance of disintegration testing in pharmaceutical development. Dissolution Technologies, v. 25, n. 3, p. 30-38, 2018Tradução . . Disponível em: https://doi.org/10.14227/DT250318P30. Acesso em: 02 maio 2024.
    • APA

      Silva, D. A., Webster, G. K., Bou-Chacra, N. A., & Löbenberg, R. (2018). The Significance of disintegration testing in pharmaceutical development. Dissolution Technologies, 25( 3), 30-38. doi:10.14227/DT250318P30
    • NLM

      Silva DA, Webster GK, Bou-Chacra NA, Löbenberg R. The Significance of disintegration testing in pharmaceutical development [Internet]. Dissolution Technologies. 2018 ; 25( 3): 30-38.[citado 2024 maio 02 ] Available from: https://doi.org/10.14227/DT250318P30
    • Vancouver

      Silva DA, Webster GK, Bou-Chacra NA, Löbenberg R. The Significance of disintegration testing in pharmaceutical development [Internet]. Dissolution Technologies. 2018 ; 25( 3): 30-38.[citado 2024 maio 02 ] Available from: https://doi.org/10.14227/DT250318P30
  • Source: Dissolution Technologies. Unidade: FCF

    Subjects: SOLUBILIDADE, FÁRMACOS, HIPERTENSÃO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DUQUE, Marcelo Dutra et al. In silico simulation of dissolution profiles for development of extended-release doxazosin tablets. Dissolution Technologies, v. 25, n. 4, p. 14-21, 2018Tradução . . Disponível em: https://doi.org/10.14227/DT250418P14. Acesso em: 02 maio 2024.
    • APA

      Duque, M. D., Issa, M. G., Silva, D. A., Barbosa, E. J., Löbenberg, R., & Ferraz, H. G. (2018). In silico simulation of dissolution profiles for development of extended-release doxazosin tablets. Dissolution Technologies, 25( 4), 14-21. doi:10.14227/DT250418P14
    • NLM

      Duque MD, Issa MG, Silva DA, Barbosa EJ, Löbenberg R, Ferraz HG. In silico simulation of dissolution profiles for development of extended-release doxazosin tablets [Internet]. Dissolution Technologies. 2018 ; 25( 4): 14-21.[citado 2024 maio 02 ] Available from: https://doi.org/10.14227/DT250418P14
    • Vancouver

      Duque MD, Issa MG, Silva DA, Barbosa EJ, Löbenberg R, Ferraz HG. In silico simulation of dissolution profiles for development of extended-release doxazosin tablets [Internet]. Dissolution Technologies. 2018 ; 25( 4): 14-21.[citado 2024 maio 02 ] Available from: https://doi.org/10.14227/DT250418P14
  • Source: Dissolution Technologies. Unidade: FCF

    Subjects: CÁPSULAS, RUPTURA DOS MATERIAIS, TESTES ENZIMÁTICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BACHOUR, Ghada e BOU-CHACRA, Nadia Araci e LÖBENBERG, Raimar. Evaluation of the rupture test for stability studies of soft-shell capsules. Dissolution Technologies, v. 24, n. 2, p. 16-19, 2017Tradução . . Disponível em: https://doi.org/10.14227/DT240217P16. Acesso em: 02 maio 2024.
    • APA

      Bachour, G., Bou-Chacra, N. A., & Löbenberg, R. (2017). Evaluation of the rupture test for stability studies of soft-shell capsules. Dissolution Technologies, 24( 2), 16-19. doi:10.14227/DT240217P16
    • NLM

      Bachour G, Bou-Chacra NA, Löbenberg R. Evaluation of the rupture test for stability studies of soft-shell capsules [Internet]. Dissolution Technologies. 2017 ; 24( 2): 16-19.[citado 2024 maio 02 ] Available from: https://doi.org/10.14227/DT240217P16
    • Vancouver

      Bachour G, Bou-Chacra NA, Löbenberg R. Evaluation of the rupture test for stability studies of soft-shell capsules [Internet]. Dissolution Technologies. 2017 ; 24( 2): 16-19.[citado 2024 maio 02 ] Available from: https://doi.org/10.14227/DT240217P16
  • Source: Dissolution Technologies. Unidade: FCF

    Subjects: SOLUBILIDADE, FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DUQUE, Marcelo Dutra et al. Intrinsic dissolution simulation of highly and poorly soluble drugs for BCS solubility classification. Dissolution Technologies, v. 24, n. 4, p. 6-11, 2017Tradução . . Disponível em: https://doi.org/10.14227/DT240417P6. Acesso em: 02 maio 2024.
    • APA

      Duque, M. D., Issa, M. G., Silva, D. A., Kakuda, B. A. S., Rodrigues, L. N. C., Löbenberg, R., & Ferraz, H. G. (2017). Intrinsic dissolution simulation of highly and poorly soluble drugs for BCS solubility classification. Dissolution Technologies, 24( 4), 6-11. doi:10.14227/DT240417P6
    • NLM

      Duque MD, Issa MG, Silva DA, Kakuda BAS, Rodrigues LNC, Löbenberg R, Ferraz HG. Intrinsic dissolution simulation of highly and poorly soluble drugs for BCS solubility classification [Internet]. Dissolution Technologies. 2017 ; 24( 4): 6-11.[citado 2024 maio 02 ] Available from: https://doi.org/10.14227/DT240417P6
    • Vancouver

      Duque MD, Issa MG, Silva DA, Kakuda BAS, Rodrigues LNC, Löbenberg R, Ferraz HG. Intrinsic dissolution simulation of highly and poorly soluble drugs for BCS solubility classification [Internet]. Dissolution Technologies. 2017 ; 24( 4): 6-11.[citado 2024 maio 02 ] Available from: https://doi.org/10.14227/DT240417P6
  • Source: Dissolution Technologies. Unidade: FCF

    Subjects: BIODISPONIBILIDADE, BIOEQUIVALÊNCIA

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ISSA, Michele Georges e FERRAZ, Humberto Gomes. Intrinsic dissolution as a tool for evaluating drug solubility in accordance with the biopharmaceutics classification system. Dissolution Technologies, v. 18, n. 3, p. 6-13, 2011Tradução . . Disponível em: http://www.dissolutiontech.com/DTresour/201108Articles/DT201108_A01.pdf. Acesso em: 02 maio 2024.
    • APA

      Issa, M. G., & Ferraz, H. G. (2011). Intrinsic dissolution as a tool for evaluating drug solubility in accordance with the biopharmaceutics classification system. Dissolution Technologies, 18( 3), 6-13. Recuperado de http://www.dissolutiontech.com/DTresour/201108Articles/DT201108_A01.pdf
    • NLM

      Issa MG, Ferraz HG. Intrinsic dissolution as a tool for evaluating drug solubility in accordance with the biopharmaceutics classification system [Internet]. Dissolution Technologies. 2011 ; 18( 3): 6-13.[citado 2024 maio 02 ] Available from: http://www.dissolutiontech.com/DTresour/201108Articles/DT201108_A01.pdf
    • Vancouver

      Issa MG, Ferraz HG. Intrinsic dissolution as a tool for evaluating drug solubility in accordance with the biopharmaceutics classification system [Internet]. Dissolution Technologies. 2011 ; 18( 3): 6-13.[citado 2024 maio 02 ] Available from: http://www.dissolutiontech.com/DTresour/201108Articles/DT201108_A01.pdf

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024